Additional file 1: Figure S1. of Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model

Validation of the mice as its own control in mice pre-irradiated at the right mammary gland. D2A1 tumor volumes of sham irradiated animals (sham tumors) were compared to control tumors (left side) of pre-irradiated animals. Error bars indicate s.e.m. for n = 6 to 15 animals for each group. (TIF 224 kb

Additional file 5: Figure S5. of Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model

Hormonal status of D2A1 cell line was confirmed by immunohistochemistry as described in Materials and Methods. No nuclear (ER and PR) as well as membrane (HER2) staining were observed. D2A1 cells were then revealed to be triple negative by a pathologist of our institution. (TIF 9131 kb

Additional file 4: Figure S4. of Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model

Quantitative densitometry from Western blots of the expression of (A) LCB3I, (B) LCB3II (Sham-CQ 60 vs IRR-CQ 60; P = 0.0024, CTL-CQ 60 vs IRR-CQ 60; P = 0.0182, IRR-VH vs IRR-CQ 60; P = 0.0009) and (C) p62 autophagy markers calculated using ImageJ Gel Analyze function

MOESM7 of The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

Additional file 7: Table S7. Proteins identification (NR, PR and TR)

MOESM5 of The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

Additional file 5: Table S5. Proteins differentially expressed between non-responders (NR) and responders (PR+TR)

MOESM4 of The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

Additional file 4: Table S4. Proteins differentially expressed between PR and PR

Additional file 1: Figure S1. of Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer

Specificity of the SOCS1 Ab. (PDF 569 kb

Additional file 2: Figure S2. of Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer

Lack of correlation between SOCS1 gene expression in PCa specimens and patient survival. (PDF 201 kb